Can a gout drug help advanced liver cancer patients live longer?
NCT ID NCT04264260
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 33 times
Summary
This study tested colchicine, a medicine usually used for gout, in 42 adults with advanced liver cancer that cannot be cured. The goal was to see if it could help patients live longer and reduce symptoms. Participants took colchicine pills in cycles, and the study compared their survival to similar patients not in the trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA STAGE IIIB are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Medical University Hospital
Kaohsiung City, 807, Taiwan
Conditions
Explore the condition pages connected to this study.